Management of Cardiovascular Disease Prevention in Primary Care; a Holistic Approach - Live Webinar

Cardiovascular disease (CVD) is the leading cause of death globally and even in developed nations poses a significant health, social and economic burden. More than 10% of the UK population (7.6 million) live with CVD, with an estimated prevalence that is double that of Alzheimer’s disease and cancer combined¹.

CVD has been identified as a key target by the UK government, Public Health England, NHS England and NHS Improvement. In an effort to tackle CVD, the NHS Long Term Plan has created specific targets in reduction of mortality through CVD risk prevention, with guidance on the importance of collaborative action between stakeholders. COVID-19 has undoubtedly caused huge disruptions in healthcare delivery; however, the front against CVD remains united and lessons have been learnt through the management of this pandemic. With growing support from national organisations, there are reasons for optimism.

As we emerge from the pandemic there is the challenge of dealing with its wider impact on health but also an opportunity to embrace new ways of working².

During this patient case-based webinar you will have the opportunity to explore the central aims of the NHS Long Term Plan to improve CVD prevention and management, with the goal of improving quality of care for patients at risk of CV events.

Based on recent literature, we now have a better understanding of the impact of atrial fibrillation on morbidity and mortality, relevant to CVD and renal disease. ³ As such, this webinar will look at the practical implementation of the guidelines in a holistic way implementing the Detect, Protect and Perfect national agenda on Stroke prevention in Atrial Fibrillation.

¹. https://bjcardio.co.uk/2021/09/cardiovascular-disease-the-state-of-the-nation-and-the-nhs-long-term-plan/

².  https://ukhsa.blog.gov.uk/2021/02/12/cardiovascular-disease-building-back-better/

³. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482. https://doi.org/10.1136/bmj.i4482